![](/img/cover-not-exists.png)
E51A mono institutional retrospective analysis on the safety and efficacy of first-line Folfiri or Folfox (CT) plus bevacizumab (B) in young and elderly patients with metastatic colorectal cancer (MCC)
Chilelli, M.G., Signorelli, C., Fabbri, A., Moscetti, L., D'Auria, G., Nelli, F., Padalino, D., Primi, F., Sperduti, I., Blandino, C., Ruggeri, E.M.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv340.51
Date:
October, 2015
File:
PDF, 33 KB
english, 2015